Clinical Practice Guideline for detection and management of diabetic kidney disease: A consensus report by the Spanish Society of Nephrology
To address all the changes in the management of people with diabetes (DM) and chronic kidney disease (CKD), under the auspices of the Spanish Society of Nephrology (SEN), the Spanish Diabetic Nephropathy Study Group (GEENDIAB) decided to publish an updated Clinical Practice Guideline for detection a...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-04-01
|
| Series: | Nefrología (English Edition) |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2013251425000550 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850188578500378624 |
|---|---|
| author | Nuria Montero Laia Oliveras Alberto Martínez-Castelao José Luis Gorriz María José Soler Beatriz Fernández-Fernández Maria Quero Clara García-Carro Paula Garcia-Sancho Marian Goicoechea Juan Jose Gorgojo Martínez Pablo Molina María Jesús Puchades Diana Rodríguez-Espinosa Nery Sablón Rafael Santamaría Juan Francisco Navarro-González |
| author_facet | Nuria Montero Laia Oliveras Alberto Martínez-Castelao José Luis Gorriz María José Soler Beatriz Fernández-Fernández Maria Quero Clara García-Carro Paula Garcia-Sancho Marian Goicoechea Juan Jose Gorgojo Martínez Pablo Molina María Jesús Puchades Diana Rodríguez-Espinosa Nery Sablón Rafael Santamaría Juan Francisco Navarro-González |
| author_sort | Nuria Montero |
| collection | DOAJ |
| description | To address all the changes in the management of people with diabetes (DM) and chronic kidney disease (CKD), under the auspices of the Spanish Society of Nephrology (SEN), the Spanish Diabetic Nephropathy Study Group (GEENDIAB) decided to publish an updated Clinical Practice Guideline for detection and management of diabetic kidney disease (DKD). It is aimed at a wide audience of clinicians treating diabetes and CKD. The terminology of kidney disease in diabetic patients has evolved toward a more inclusive nomenclature that avoids underdiagnosis of this entity. Thus, the terms “diabetes and kidney disease” and “diabetic kidney disease” are those proposed in the latest KDIGO 2022 guidelines to designate the whole spectrum of patients who can benefit from a comprehensive therapeutic approach only differentiated according to eGFR range and albuminuria.Recommendations have been divided into five main areas of interest: Chapter 1: Screening and diagnosis of diabetic kidney disease, Chapter 2: Metabolic control in people with diabetes and CKD, Chapter 3: Blood pressure control in people with diabetic kidney disease, Chapter 4: Treatment targeting progression of CKD in people with diabetic kidney disease, and Chapter 5: Antiplatelet or anticoagulant therapy in people with diabetes and CKD.World Health Organization (WHO) recommendations for guideline development were followed to report this guideline. Systematic reviews were carried out, with outcome ratings and summaries of findings, and we reported the strength of recommendations following the “Grading of Recommendations Assessment, Development and Evaluation” GRADE evidence profiles. Resumen: Para abordar todas las novedades en el manejo de las personas con diabetes (DM) y enfermedad renal crónica (ERC), el Grupo Español de Estudio de Nefropatía Diabética (GEENDIAB), bajo los auspicios de la Sociedad Española de Nefrología (SEN), ha decidido publicar una Actualización de la Guía de Práctica Clínica para la detección y el manejo de la ERC, dirigida a una amplia audiencia de clínicos que tratan la diabetes y la ERC. La terminología de la enfermedad renal en los pacientes diabéticos ha evolucionado hacia una nomenclatura más inclusiva que evita el infradiagnóstico de esta entidad. Así, los términos «diabetes y enfermedad renal» y «enfermedad renal diabética» son los propuestos en las últimas guías KDIGO 2022 para designar a todo el espectro de pacientes que pueden beneficiarse de un abordaje terapéutico integral, solo diferenciado según el rango de la FGe y la albuminuria.Las recomendaciones se han dividido en 5 áreas principales de interés: Capítulo 1: Cribado y diagnóstico de la enfermedad renal diabética; Capítulo 2: Control metabólico en personas con diabetes y ERC; Capítulo 3: Control de la presión arterial en personas con enfermedad renal diabética; Capítulo 4: Tratamiento dirigido a la progresión de la ERC en personas con enfermedad renal diabética y Capítulo 5: Tratamiento antiagregante plaquetario o anticoagulante en personas con diabetes y ERC.Para elaborar esta guía se siguieron las recomendaciones de la Organización Mundial de la Salud (OMS) para el desarrollo de guías. Se realizaron revisiones sistemáticas, con evaluación de los resultados y resúmenes de los hallazgos, y se informó de la fuerza de las recomendaciones siguiendo los perfiles de evidencia Grading of Recommendations Assessment, Development and Evaluation (GRADE). |
| format | Article |
| id | doaj-art-2709959ea3ae40a2814ef7963bdac38a |
| institution | OA Journals |
| issn | 2013-2514 |
| language | English |
| publishDate | 2025-04-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Nefrología (English Edition) |
| spelling | doaj-art-2709959ea3ae40a2814ef7963bdac38a2025-08-20T02:15:51ZengElsevierNefrología (English Edition)2013-25142025-04-014512610.1016/j.nefroe.2025.04.005Clinical Practice Guideline for detection and management of diabetic kidney disease: A consensus report by the Spanish Society of NephrologyNuria Montero0Laia Oliveras1Alberto Martínez-Castelao2José Luis Gorriz3María José Soler4Beatriz Fernández-Fernández5Maria Quero6Clara García-Carro7Paula Garcia-Sancho8Marian Goicoechea9Juan Jose Gorgojo Martínez10Pablo Molina11María Jesús Puchades12Diana Rodríguez-Espinosa13Nery Sablón14Rafael Santamaría15Juan Francisco Navarro-González16Department of Nephrology, Hospital Universitari de Bellvitge, L’Hospitalet de Llobregat, Barcelona, Spain; Corresponding authors.Department of Nephrology, Hospital Universitari de Bellvitge, L’Hospitalet de Llobregat, Barcelona, SpainDepartment of Nephrology, Hospital Universitari de Bellvitge, L’Hospitalet de Llobregat, Barcelona, Spain; RICORS2040 Kidney Disease (RD21/0005/0013), SpainDepartment of Nephrology, Hospital Clínico Universitario de València, Universitat de València, València, SpainDepartment of Nephrology, Hospital Universitari Vall d’Hebron, Vall d’Hebron Institute of Research, Barcelona, SpainDepartment of Nephrology and Hypertension, IIS-Fundación Jiménez Díaz, RICORS2040, Department of Medicine, Facultad de Medicina, Universidad Autónoma de Madrid, Madrid, SpainDepartment of Nephrology, Hospital Universitari de Bellvitge, L’Hospitalet de Llobregat, Barcelona, SpainDepartment of Nephrology, Hospital Universitario Clínico San Carlos, Universidad Complutense de Madrid, Madrid, SpainDepartment of Endocrinology and Nutrition, Complex Hospitalari Universitari Moises Broggi, Barcelona, SpainDepartment of Nephrology, Hospital General Universitario Gregorio Marañón, RICORS 2040 Kidney Disease, SpainDepartment of Endocrinology and Nutrition, Hospital Universitario Fundación Alcorcón, Madrid, SpainDepartment of Nephrology, FISABIO, Hospital Universitari Dr. Peset, Universitat de València, València, SpainNephrology Unit, Hospital Clínico Universitario de València, Universitat de València, València, SpainDepartment of Nephrology, Hospital Clínic de Barcelona, Barcelona, SpainDepartment of Nephrology, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, SpainDepartment of Nephrology, Hospital Universitario Reina Sofía, Maimonides Biomedical Research Institute of Cordoba (IMIBIC)/University of Cordoba, Córdoba, SpainResearch Unit and Department of Nephrology, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain; RICORS2040 Kidney Disease (RD21/0005/0013), Instituto de Salud Carlos III, Madrid, Spain; Instituto de Tecnologías Biomédicas, Universidad de La Laguna, Tenerife, Spain; Facultad de Ciencias de la Salud, Universidad Fernando Pessoa Canarias, Las Palmas de Gran Canaria, Spain; Corresponding authors.To address all the changes in the management of people with diabetes (DM) and chronic kidney disease (CKD), under the auspices of the Spanish Society of Nephrology (SEN), the Spanish Diabetic Nephropathy Study Group (GEENDIAB) decided to publish an updated Clinical Practice Guideline for detection and management of diabetic kidney disease (DKD). It is aimed at a wide audience of clinicians treating diabetes and CKD. The terminology of kidney disease in diabetic patients has evolved toward a more inclusive nomenclature that avoids underdiagnosis of this entity. Thus, the terms “diabetes and kidney disease” and “diabetic kidney disease” are those proposed in the latest KDIGO 2022 guidelines to designate the whole spectrum of patients who can benefit from a comprehensive therapeutic approach only differentiated according to eGFR range and albuminuria.Recommendations have been divided into five main areas of interest: Chapter 1: Screening and diagnosis of diabetic kidney disease, Chapter 2: Metabolic control in people with diabetes and CKD, Chapter 3: Blood pressure control in people with diabetic kidney disease, Chapter 4: Treatment targeting progression of CKD in people with diabetic kidney disease, and Chapter 5: Antiplatelet or anticoagulant therapy in people with diabetes and CKD.World Health Organization (WHO) recommendations for guideline development were followed to report this guideline. Systematic reviews were carried out, with outcome ratings and summaries of findings, and we reported the strength of recommendations following the “Grading of Recommendations Assessment, Development and Evaluation” GRADE evidence profiles. Resumen: Para abordar todas las novedades en el manejo de las personas con diabetes (DM) y enfermedad renal crónica (ERC), el Grupo Español de Estudio de Nefropatía Diabética (GEENDIAB), bajo los auspicios de la Sociedad Española de Nefrología (SEN), ha decidido publicar una Actualización de la Guía de Práctica Clínica para la detección y el manejo de la ERC, dirigida a una amplia audiencia de clínicos que tratan la diabetes y la ERC. La terminología de la enfermedad renal en los pacientes diabéticos ha evolucionado hacia una nomenclatura más inclusiva que evita el infradiagnóstico de esta entidad. Así, los términos «diabetes y enfermedad renal» y «enfermedad renal diabética» son los propuestos en las últimas guías KDIGO 2022 para designar a todo el espectro de pacientes que pueden beneficiarse de un abordaje terapéutico integral, solo diferenciado según el rango de la FGe y la albuminuria.Las recomendaciones se han dividido en 5 áreas principales de interés: Capítulo 1: Cribado y diagnóstico de la enfermedad renal diabética; Capítulo 2: Control metabólico en personas con diabetes y ERC; Capítulo 3: Control de la presión arterial en personas con enfermedad renal diabética; Capítulo 4: Tratamiento dirigido a la progresión de la ERC en personas con enfermedad renal diabética y Capítulo 5: Tratamiento antiagregante plaquetario o anticoagulante en personas con diabetes y ERC.Para elaborar esta guía se siguieron las recomendaciones de la Organización Mundial de la Salud (OMS) para el desarrollo de guías. Se realizaron revisiones sistemáticas, con evaluación de los resultados y resúmenes de los hallazgos, y se informó de la fuerza de las recomendaciones siguiendo los perfiles de evidencia Grading of Recommendations Assessment, Development and Evaluation (GRADE).http://www.sciencedirect.com/science/article/pii/S2013251425000550Diabetes mellitusGuías de práctica clínicaEnfermedades renales diabéticasNefropatía diabética |
| spellingShingle | Nuria Montero Laia Oliveras Alberto Martínez-Castelao José Luis Gorriz María José Soler Beatriz Fernández-Fernández Maria Quero Clara García-Carro Paula Garcia-Sancho Marian Goicoechea Juan Jose Gorgojo Martínez Pablo Molina María Jesús Puchades Diana Rodríguez-Espinosa Nery Sablón Rafael Santamaría Juan Francisco Navarro-González Clinical Practice Guideline for detection and management of diabetic kidney disease: A consensus report by the Spanish Society of Nephrology Nefrología (English Edition) Diabetes mellitus Guías de práctica clínica Enfermedades renales diabéticas Nefropatía diabética |
| title | Clinical Practice Guideline for detection and management of diabetic kidney disease: A consensus report by the Spanish Society of Nephrology |
| title_full | Clinical Practice Guideline for detection and management of diabetic kidney disease: A consensus report by the Spanish Society of Nephrology |
| title_fullStr | Clinical Practice Guideline for detection and management of diabetic kidney disease: A consensus report by the Spanish Society of Nephrology |
| title_full_unstemmed | Clinical Practice Guideline for detection and management of diabetic kidney disease: A consensus report by the Spanish Society of Nephrology |
| title_short | Clinical Practice Guideline for detection and management of diabetic kidney disease: A consensus report by the Spanish Society of Nephrology |
| title_sort | clinical practice guideline for detection and management of diabetic kidney disease a consensus report by the spanish society of nephrology |
| topic | Diabetes mellitus Guías de práctica clínica Enfermedades renales diabéticas Nefropatía diabética |
| url | http://www.sciencedirect.com/science/article/pii/S2013251425000550 |
| work_keys_str_mv | AT nuriamontero clinicalpracticeguidelinefordetectionandmanagementofdiabetickidneydiseaseaconsensusreportbythespanishsocietyofnephrology AT laiaoliveras clinicalpracticeguidelinefordetectionandmanagementofdiabetickidneydiseaseaconsensusreportbythespanishsocietyofnephrology AT albertomartinezcastelao clinicalpracticeguidelinefordetectionandmanagementofdiabetickidneydiseaseaconsensusreportbythespanishsocietyofnephrology AT joseluisgorriz clinicalpracticeguidelinefordetectionandmanagementofdiabetickidneydiseaseaconsensusreportbythespanishsocietyofnephrology AT mariajosesoler clinicalpracticeguidelinefordetectionandmanagementofdiabetickidneydiseaseaconsensusreportbythespanishsocietyofnephrology AT beatrizfernandezfernandez clinicalpracticeguidelinefordetectionandmanagementofdiabetickidneydiseaseaconsensusreportbythespanishsocietyofnephrology AT mariaquero clinicalpracticeguidelinefordetectionandmanagementofdiabetickidneydiseaseaconsensusreportbythespanishsocietyofnephrology AT claragarciacarro clinicalpracticeguidelinefordetectionandmanagementofdiabetickidneydiseaseaconsensusreportbythespanishsocietyofnephrology AT paulagarciasancho clinicalpracticeguidelinefordetectionandmanagementofdiabetickidneydiseaseaconsensusreportbythespanishsocietyofnephrology AT mariangoicoechea clinicalpracticeguidelinefordetectionandmanagementofdiabetickidneydiseaseaconsensusreportbythespanishsocietyofnephrology AT juanjosegorgojomartinez clinicalpracticeguidelinefordetectionandmanagementofdiabetickidneydiseaseaconsensusreportbythespanishsocietyofnephrology AT pablomolina clinicalpracticeguidelinefordetectionandmanagementofdiabetickidneydiseaseaconsensusreportbythespanishsocietyofnephrology AT mariajesuspuchades clinicalpracticeguidelinefordetectionandmanagementofdiabetickidneydiseaseaconsensusreportbythespanishsocietyofnephrology AT dianarodriguezespinosa clinicalpracticeguidelinefordetectionandmanagementofdiabetickidneydiseaseaconsensusreportbythespanishsocietyofnephrology AT nerysablon clinicalpracticeguidelinefordetectionandmanagementofdiabetickidneydiseaseaconsensusreportbythespanishsocietyofnephrology AT rafaelsantamaria clinicalpracticeguidelinefordetectionandmanagementofdiabetickidneydiseaseaconsensusreportbythespanishsocietyofnephrology AT juanfrancisconavarrogonzalez clinicalpracticeguidelinefordetectionandmanagementofdiabetickidneydiseaseaconsensusreportbythespanishsocietyofnephrology |